Silexion Therapeutics announces 1-for-10 reverse share split

Biomotion Sciences. Ordinary Shares

Biomotion Sciences. Ordinary Shares

SLXN

0.00
  • Silexion Therapeutics will execute a 1-for-10 reverse share split, effective after the May 28 market close.
  • Shares start trading on a split-adjusted basis on Nasdaq at the May 29 open under ticker SLXN.
  • Each 10 ordinary shares will convert into 1 share; par value rises to $0.135 from $0.0135.
  • No fractional shares will be issued; DTC participants entitled to fractions will receive rounded-up whole shares.
  • Move targets Nasdaq’s $1 minimum bid requirement, aiming to support listing compliance and future equity financing flexibility.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silexion Therapeutics Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605260830PRIMZONEFULLFEED1001183731) on May 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.